Thursday, January 17, 2008

Quetiapine Reduces Symptoms of Opioid Withdrawal

NEW YORK (Reuters Health) Nov 23 - The use of quetiapine during opioid cessation helps relieve symptoms of withdrawal method, according to a papers published in the October stock of the Leger of Clinical Psychiatry.

Dr.
Harold B.
Pinkofsky and colleagues from the Body of Pittsburgh Period of Penalisation, University of Pennsylvania, studied patients undergoing ambulatory detoxification from opioids and treated with clonidine, hydroxyzine, trazodone, diphenoxylate/atropine, and sometimes chlordiazepoxide.

In accession, patients were initially given ogdoad 25-mg tablets of quetiapine. pass drug test marijuana
- they were told to take 1 or 2 tablets every 4 work time as needed for symptoms of removal or craving (maximum daily dose 200 mg).
Doses were increased if the drug was tolerated and the participant role reported a welfare.

A quantity of 213 patients were treated with quetiapine in the medical building.
Of these, 41% completed the announcement, with at least 5 days of abstention.
After some initial attainment with quetiapine, the patients were asked to complete a drug questionnaire for quality-assurance purposes.

Of the 107 patients who completed the view, 79 (74%) reported that quetiapine helped reduce cravings for opioids and 52 (49%) said that it helped reduce withdrawal-associated emotion.
A simplification in somatic pain was reported by 24 patients (22%), and 22 patients (21%) reported that quetiapine helped alleviate insomnia.
Fourteen patients (13%) reported an advance in appetite.

Four subjects found that quetiapine had no welfare.
7 patients were not able to tolerate the drug because of side effects.
The patients received a mean quetiapine dose of 206 mg/day.

“It appears that quetiapine may play a role in opioid detoxification, although the pharmacologic mode of physical process is not known,” Dr.
Pinkofsky and colleagues write. “The results of this literary criticism suggest the need for further research.”
This is a part of article Quetiapine Reduces Symptoms of Opioid Withdrawal Taken from "Desloratadine Clarinex" Information Blog

No comments: